Exarafenib is a selective inhibitor within the tyrosine kinase inhibitor class that targets the extracellular signal-regulated kinase (ERK) family. By blocking the MAPK signaling pathway, this compound… Read more
Exarafenib is a selective inhibitor within the tyrosine kinase inhibitor class that targets the extracellular signal-regulated kinase (ERK) family. By blocking the MAPK signaling pathway, this compound functions to inhibit tumor cell proliferation, making it an important therapeutic agent for non-small cell lung cancer and other solid tumors driven by RAS mutations. Laboratories working with this compound require high-quality reference standards for rigorous analytical testing, including impurity profiling, method validation, and stability testing. This collection includes Exarafenib alongside its stable isotope labelled counterpart, such as the deuterated analogue Exarafenib-d8. These compounds serve as critical internal standards for mass spectrometry and quantitative analysis, enabling pharmaceutical quality control laboratories to accurately monitor drug substance purity and metabolism. Reliable access to these materials ensures that researchers can maintain precise compliance with regulatory standards throughout the drug development and manufacturing lifecycle.